| Literature DB >> 34199448 |
Khawla Loubani1,2, Rachel Kizony1,3, Uzi Milman2, Naomi Schreuer1.
Abstract
BACKGROUND: Women after breast cancer (BC) cope with decreased daily participation and quality of life (QOL) due to physical, cognitive, and emotional symptoms. This study examined a hybrid occupation-based intervention, Managing Participation with Breast Cancer (MaP-BC), to improve daily participation in their meaningful activities.Entities:
Keywords: activities of daily living; breast cancer; hybrid intervention; occupational therapy; self-management; tele-rehabilitation
Mesh:
Year: 2021 PMID: 34199448 PMCID: PMC8199623 DOI: 10.3390/ijerph18115966
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Managing Participation with Breast Cancer (MaP-BC); hybrid intervention protocol.
| Week | Session Type | Goals | Content and Examples |
|---|---|---|---|
| 1 | Clinic |
Present intervention contents and principals. Set woman’s meaningful functional goals. Understand post-BC women’s priorities, habits, performance, and participation. Initial training on tele-program. |
Plan dates for in-clinic and tele-rehabilitation sessions. Understand how symptoms affect woman’s performance and participation in general and specifically in the meaningful goals. Focus on one prioritized goal to attain during the first weeks. Train to use computerized tele-system during the tele-rehabilitation sessions. |
| Tele |
Install and starting training with the tele-system. |
Train motor and cognitive performance capacities. | |
| 2 | Clinic |
Present self-management (SM) strategies. Examples for training SM strategies from woman’s daily life (identify/solve problems, make decisions, use resources, set action plan). Train motor/cognitive performance capacities related to performing meaningful selected activities. Set action plan for current week. |
Understand which strategies the woman uses to deal with symptoms and their effects on her daily functioning. How does she use these strategies? (examples from her day-to-day life). Use weekly calendar to plan steps to attain one or two meaningful goals (when, how much, where.) |
| Tele |
Train motor/cognitive performance capacities related to performing selected meaningful activities. Discuss ways to transfer strategies trained at the clinic into additional daily activities at home/work/community environment. |
Gradually add additional games/tasks to exercise and raise difficulty level according to the woman’s progress. | |
| 3–5 | Clinic |
Ongoing sessions that aim to increase sense of occupational competence through gradual achievement of the selected goals. Set action plan for the next week. |
Maintain the retained goals. Progress to higher performance levels in same goal. Add goals. |
| Tele |
Discuss ways to transfer strategies trained at the clinic into additional daily activities at home/work/community environment. |
Check if the strategies are useful. If not, decide about other ways or strategies to maintain specific activity performance. | |
| 6 | Tele |
Train motor/cognitive performance capacities related to performing selected meaningful activities. | |
| Clinic |
Discuss ways and strategies to maintain functional goals and participation. Summarize intervention process. |
How to maintain the improvement? Summarize strategies used and found effective. Give summary of the strategies to the woman. |
Figure 1Randomized control trial CONSORT diagram of the study. Abbreviations: T1 = Time 1; T2 = Time 2; T3 = Time 3; MaP-BC = Managing Participation with Breast Cancer; ITT = Intention-To-Treat analysis.
Descriptive statistics and comparison of demographic and breast cancer clinical characteristics (n = 35).
| Variable | Intervention | Control | Between-Group | |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Age (years) | 48.00 (11.14) | 28–69 | 52.06 (12.80) | 31–64 | −1.00 | 33.0 |
| Education (years) | 15.06 (1.92) | 12–17 | 13.94 (2.28) | 11–17 | 1.57 | 33.0 |
| Months since diagnosis | 14.56 (5.54) | 5–25 | 11.24 (3.17) | 6–17 | 2.19 * | 27.3 |
|
|
|
|
| |||
| Marital status | ||||||
| Married | 11 (61.10) | 12 (70.60) | 0.35 | 1.0 | ||
| Other | 7 (38.90) | 5 (34.40) | ||||
| BC stage | ||||||
| 1 | 2 (11.10) | 6 (35.30) | 3.64 | 2.0 | ||
| 2 | 10 (55.60) | 5 (29.40) | ||||
| 3 | 6 (33.30) | 6 (35.30) | ||||
| Surgery | ||||||
| Lumpectomy | 10 (55.60) | 13 (76.50) | 1.70 | 1.0 | ||
| Mastectomy | 8 (44.40) | 4 (23.50) | ||||
| Medical therapy upon diagnosis | ||||||
| Chemo | 14 (77.80) | 11 (64.70) | 0.73 | 1.0 | ||
| Radio | 13 (72.20) | 12 (75.00) | 0.03 | 1.0 | ||
| Hormonal | 10 (55.60) | 13 (81.30) | 2.56 | 1.0 | ||
| Additional therapy | ||||||
| Lymphatic | 5 (27.80) | 4 (23.50) | 0.24 | 2.0 | ||
| None | 6 (33.30) | 7 (41.20) | ||||
| Other | 7 (38.90) | 6 (35.30) | ||||
* p = 0.037.
Descriptive statistics and results of within- and between-parametric group comparisons at T1, T2, and T3.
| Measure | Intervention Group ( | Control Group ( | Group Effect | Time Effect | Interaction | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T1 | T2 | T3 | T1 | T2 | T3 |
| ηp2 |
| ηp2 |
| ηp2 | ||||
| COPM | |||||||||||||||
| PCOPM | 3.83 (1.60) | 6.01 (1.84) | 6.15 (1.84) | 4.01 (1.76) | 4.90 (1.85) | 5.35 (1.91) | 1.18 | 0.286 | 0.034 |
| 0.0001 | 0.472 |
| 0.036 | 0.096 |
| SCOPM | 2.63 (1.61) | 5.88 (2.64) | 6.04 (2.45) | 3.34 (1.58) | 4.84 (2.11) | 5.12 (2.41) | 0.44 | 0.511 | 0.013 |
| 0.0001 | 0.530 |
| 0.018 | 0.115 |
| ACS RAL | |||||||||||||||
| Total | 0.69 (0.18) | 0.73 (0.20) | 0.74 (0.20) | 0.58 (0.20) | 0.61 (0.20) | 0.59 (0.18) |
| 0.039 | 0.123 | 1.34 | 0.269 | 0.039 | 0.190 | 0.827 | 0.006 |
| IADL | 0.68 (0.20) | 0.74 (0.23) | 0.72 (0.23) | 0.60 (0.22) | 0.62 (0.23) | 0.63 (0.20) | 2.10 | 0.157 | 0.060 | 1.36 | 0.264 | 0.040 | 0.41 | 0.666 | 0.012 |
| Social | 0.65 (0.22) | 0.73 (0.24) | 0.69 (0.24) | 0.53 (0.28) | 0.56 (0.28) | 0.47 (0.23) |
| 0.026 | 0.141 | 1.88 | 0.161 | 0.054 | 0.96 | 0.388 | 0.028 |
| Motor performance | |||||||||||||||
| DASH | 48.19 (20.25) | 37.67 (22.13) | 34.72 (21.26) | 49.19 (20.58) | 44.02 (22.93) | 44.57 (22.73) | 0.70 | 0.407 | 0.021 | 9.28 | 0.0001 | 0.219 | 1.91 | 0.157 | 0.055 |
| Grip | 17.95 (5.98) | 18.99 (4.93) | 20.20 (5.63) | 16.61 (5.39) | 17.33 (5.79) | 16.73 (5.78) | 1.54 | 0.224 | 0.044 | 1.86 | 0.165 | 0.053 | 1.62 | 0.206 | 0.047 |
| Cognitive (BRIEF-A) | |||||||||||||||
| GEC | 64.33 (12.68) | 58.44 (11.34) | 58.44 (12.56) | 62.18 (12.19 | 60.00 (8.67) | 57.64 (10.80) | 0.02 | 0.893 | 0.001 |
|
| 0.195 | 0.95 | 0.394 | 0.028 |
| BRI | 58.17 (12.87) | 54.39 (12.17) | 54.94 (13.45) | 58.35 (12.68) | 56.12 (9.16) | 53.41 (10.02) | 0.02 | 0.900 | 0.0001 |
|
| 0.098 | 0.32 | 0.724 | 0.010 |
| MI | 63.28 (12.81) | 56.94 (10.60) | 56.50 (11.46) | 59.71 (12.60) | 57.94 (9.11) | 55.41 (9.83) | 0.12 | 0.727 | 0.004 |
|
| 0.228 | 1.55 | 0.219 | 0.045 |
| FACT-B | |||||||||||||||
| Total | 91.55 (20.11) | 99.12 (21.24) | 100.75 (23.05) | 89.13 (14.82) | 94.99 (16.28) | 95.31 (16.83) | 0.44 | 0.510 | 0.0130 |
|
| 0.205 | 0.28 | 0.758 | 0.008 |
| EWB | 15.89 (4.31) | 17.11 (4.78) | 17.22 (4.60) | 16.06 (4.02) | 17.18 (5.02) | 16.82 (4.60) | 0.00 | 0.969 | 0.0000 | 2.28 | 0.110 | 0.065 | 1.30 | 0.882 | 0.004 |
Partial eta square (ηp2) was calculated as effect size: small (0.02–0.13), moderate (0.13–0.26), large (>0.26) [52]. Statistically significant values in bold font. Abbreviations: ACS RAL = Activity Card Sort, retained activity level; BRIEF-A = Behavior Rating Inventory of Executive Function-adult version; COPM = Canadian Occupational Performance Measure; EWB = emotional well-being; FACT-B = Functional Assessment of Cancer Therapy-Breast; GEC = BRIEF-A global executive composite; IADL = instrumental activities of daily living; Quick-DASH = quick version of the Disability of Arm, Shoulder, Hand; SCOPM = COPM performance satisfaction.
Descriptive statistics and results of within-nonparametric group comparisons.
| Measure | Median | Freidman Test | |||||
|---|---|---|---|---|---|---|---|
| T1 | T2 | T3 | χ2 (df = 2) | T1–T2 | T2–T3 | T1–T3 | |
| Intervention group ( | |||||||
| ACS (high-leisure RAL) | 0.50 | 0.67 | 0.70 | 8.58 | −0.53 | −1.90 | 2.45 |
| ACS (low-leisure RAL) | 0.81 | 0.78 | 0.82 | 1.05 | −0.31 | −0.57 | −0.16 |
| Cognitive performance capacity (MOCA) | 27.00 | 27.50 | 29.00 | 11.68 | −1.38 | −2.10 | −2.89 |
| Control group ( | |||||||
| ACS (high-leisure RAL) | 0.50 | 0.42 | 0.50 | 1.45 | −1.02 | −0.20 | −1.13 |
| ACS (low-leisure RAL) | 0.75 | 0.75 | 0.75 | 2.26 | −1.38 | −0.16 | −1.10 |
| Cognitive performance capacity (MOCA) | 26.00 | 27.00 | 26.00 | 5.70 | −1.91 | −0.07 | −1.56 |
Abbreviations: ACS RAL = Activity Card Sort, retained activity level; MOCA = Montreal Cognitive Assessment.